Efficacy of lentivirus-mediated gene therapy in an Omenn syndrome recombination-activating gene 2 mouse model is not hindered by inflammation and immune dysregulation

V Capo; MC Castiello; E Fontana; S Penna; M Bosticardo; E Draghici; LP Poliani; LS Sergi; R Rigoni; B Cassani; M Zanussi; P Carrera; P Uva; K Dobbs; N Sacchetti; LD Notarangelo; Niek Til; Gerard Wagemaker; A Villa

doi:10.1016/j.jaci.2017.11.015

Efficacy of lentivirus-mediated gene therapy in an Omenn syndrome recombination-activating gene 2 mouse model is not hindered by inflammation and immune dysregulation

V Capo, MC Castiello, E Fontana, S Penna, M Bosticardo, E Draghici, LP Poliani, LS Sergi, R Rigoni, B Cassani, M Zanussi, P Carrera, P Uva, K Dobbs, N Sacchetti, LD Notarangelo, Niek Til, Gerard Wagemaker, A Villa

Hematology

Research output: Contribution to journal › Article › Academic › peer-review

25 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	928-941.e8
Journal	Journal of Allergy and Clinical Immunology
Volume	142
Issue number	3
DOIs	https://doi.org/10.1016/j.jaci.2017.11.015
Publication status	Published - 2018

Research programs

EMC OR-01

Access to Document

10.1016/j.jaci.2017.11.015

http://hdl.handle.net/1765/104059

Cite this

Capo, V., Castiello, MC., Fontana, E., Penna, S., Bosticardo, M., Draghici, E., Poliani, LP., Sergi, LS., Rigoni, R., Cassani, B., Zanussi, M., Carrera, P., Uva, P., Dobbs, K., Sacchetti, N., Notarangelo, LD., Til, N., Wagemaker, G., & Villa, A. (2018). Efficacy of lentivirus-mediated gene therapy in an Omenn syndrome recombination-activating gene 2 mouse model is not hindered by inflammation and immune dysregulation. Journal of Allergy and Clinical Immunology, 142(3), 928-941.e8. https://doi.org/10.1016/j.jaci.2017.11.015

@article{8ab9fa9120684f70ae161e0f57d49484,

title = "Efficacy of lentivirus-mediated gene therapy in an Omenn syndrome recombination-activating gene 2 mouse model is not hindered by inflammation and immune dysregulation",

author = "V Capo and MC Castiello and E Fontana and S Penna and M Bosticardo and E Draghici and LP Poliani and LS Sergi and R Rigoni and B Cassani and M Zanussi and P Carrera and P Uva and K Dobbs and N Sacchetti and LD Notarangelo and Niek Til and Gerard Wagemaker and A Villa",

year = "2018",

doi = "10.1016/j.jaci.2017.11.015",

language = "Undefined/Unknown",

volume = "142",

pages = "928--941.e8",

journal = "Journal of Allergy and Clinical Immunology",

issn = "0091-6749",

publisher = "Elsevier Inc.",

number = "3",

}

Capo, V, Castiello, MC, Fontana, E, Penna, S, Bosticardo, M, Draghici, E, Poliani, LP, Sergi, LS, Rigoni, R, Cassani, B, Zanussi, M, Carrera, P, Uva, P, Dobbs, K, Sacchetti, N, Notarangelo, LD, Til, N, Wagemaker, G & Villa, A 2018, 'Efficacy of lentivirus-mediated gene therapy in an Omenn syndrome recombination-activating gene 2 mouse model is not hindered by inflammation and immune dysregulation', Journal of Allergy and Clinical Immunology, vol. 142, no. 3, pp. 928-941.e8. https://doi.org/10.1016/j.jaci.2017.11.015

Efficacy of lentivirus-mediated gene therapy in an Omenn syndrome recombination-activating gene 2 mouse model is not hindered by inflammation and immune dysregulation. / Capo, V; Castiello, MC; Fontana, E et al.
In: Journal of Allergy and Clinical Immunology, Vol. 142, No. 3, 2018, p. 928-941.e8.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Efficacy of lentivirus-mediated gene therapy in an Omenn syndrome recombination-activating gene 2 mouse model is not hindered by inflammation and immune dysregulation

AU - Capo, V

AU - Castiello, MC

AU - Fontana, E

AU - Penna, S

AU - Bosticardo, M

AU - Draghici, E

AU - Poliani, LP

AU - Sergi, LS

AU - Rigoni, R

AU - Cassani, B

AU - Zanussi, M

AU - Carrera, P

AU - Uva, P

AU - Dobbs, K

AU - Sacchetti, N

AU - Notarangelo, LD

AU - Til, Niek

AU - Wagemaker, Gerard

AU - Villa, A

PY - 2018

Y1 - 2018

U2 - 10.1016/j.jaci.2017.11.015

DO - 10.1016/j.jaci.2017.11.015

M3 - Article

SN - 0091-6749

VL - 142

SP - 928-941.e8

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

IS - 3

ER -